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Article

Dendritic cells induce antigen-specific
regulatory T cells that prevent graft versus
host disease and persist in mice
Uri Sela, Peter Olds, Andrew Park, Sarah J. Schlesinger, and Ralph M. Steinman

The Journal of Experimental Medicine

Foxp3+ regulatory T cells (T reg cells) effectively suppress immunity, but it is not determined
if antigen-induced T reg cells (iT reg cells) are able to persist under conditions of inflammation and to stably express the transcription factor Foxp3. We used spleen cells to stimulate
the mixed leukocyte reaction (MLR) in the presence of transforming growth factor  (TGF-)
and retinoic acid. We found that the CD11chigh dendritic cell fraction was the most potent
at inducing high numbers of alloreactive Foxp3+ cells. The induced CD4+CD25+Foxp3+ cells
appeared after extensive proliferation. When purified from the MLR, iT reg cells suppressed
both primary and secondary MLR in vitro in an antigen-specific manner. After transfer into
allogeneic mice, iT reg cells persisted for 6 mo and prevented graft versus host disease
(GVHD) caused by co-transferred CD45RBhi T cells. Similar findings were made when iT reg
cells were transferred after onset of GVHD. The CNS2 intronic sequence of the Foxp3 gene
in the persisting iT reg cells was as demethylated as the corresponding sequence of naturally
occurring T reg cells. These results indicate that induced Foxp3+ T reg cells, after proliferating and differentiating into antigen-specific suppressive T cells, can persist for long periods
while suppressing a powerful inflammatory disease.
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Ralph M. Steinman:
steinma@rockefeller.edu
OR
Uri Sela:
usela@rockefeller.edu
Abbreviations used: ATRA, alltrans retinoic acid; CNS, conserved noncoding sequence;
GVHD, graft versus host disease;
MLR, mixed leukocyte reaction.

Regulatory T cells (T reg cells) that express the
Foxp3 transcription factor and suppress immunity are generated in the thymus and are called
nT reg cells (Marie et al., 2005; Sakaguchi,
2005). CD4+Foxp3+ T reg cells are also induced
(iT reg cells) in the periphery upon TCR stimulation in the presence of TGF- (Shevach
et al., 2008) with either anti-CD3 (Chen et al.,
2003) or antigen-presenting DCs (Luo et al.,
2007;Yamazaki et al., 2007).The vitamin A me
tabolite all-trans retinoic acid (ATRA) enhances
iT reg cell formation along with TGF- (Benson
et al., 2007; Coombes et al., 2007; Mucida et al.,
2007; Sun et al., 2007; von Boehmer, 2007;
Hill et al., 2008). Antigen-specific iT reg cells
have the potential to suppress autoimmunity,
allergy, and transplantation (Horwitz et al., 2004).
However, a major gap, which limits their therapeutic use, is to sustain Foxp3 expression after
adoptive transfer in vivo (Sakaguchi et al., 2008;
Edinger, 2009).
In the case of nT reg cells, adoptively transferred polyclonal populations can ameliorate
immune pathology (Roncarolo and Battaglia,
2007) and recently were found to exhibit stability
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under physiological and inflammatory conditions (Rubtsov et al., 2010). Nevertheless, there
are several studies reporting that T reg cells
lower their expression of the essential transcription factor Foxp3 in the context of inflammation (Wan and Flavell, 2007; Tang et al.,
2008; Murai et al., 2009; Zhou et al., 2009).
Less certain, however, is whether iT reg cells,
especially antigen-specific iT reg cells induced
in vitro, can sustain Foxp3 expression and
suppressive function upon reengagement with
antigen in vivo (Sakaguchi et al., 2008; Edinger,
2009).The instability of iT reg cells is attributed at least in part to a low demethylation
status of specific conserved noncoding sequences
(CNSs) in the Foxp3 gene, which are fully
demethylated in nT reg cells (Floess et al., 2007;
Kim and Leonard, 2007; Polansky et al., 2008;
Zheng et al., 2010).
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In this paper, we will show that induced Foxp3+ T reg
cells can have many features of an adaptive immune response.
We find that mouse spleen DCs are specialized inducers of
antigen-specific and suppressive iT reg cells from the alloreactive T cell repertoire, in the presence of exogenous TGF-
and ATRA. Although prior studies either failed to restimulate
iT reg cells (Floess et al., 2007) or required exogenous addition of the suppressive cytokine TGF- (Polansky et al., 2008;
Koenecke et al., 2009), a cytokine which might not be available under inflammatory condition in vivo, we observe that
iT reg cells can be restimulated specifically by DCs in vitro in
the absence of TGF-. Importantly, the DC-induced Foxp3+
iT reg cells suppress graft versus host disease (GVHD), maintaining foxp3 expression for 6 mo and acquiring a demethylated foxp3 CNS2 sequence comparable to nT reg cells.
RESULTS
DCs induce antigen-specific suppressive iT reg cells
from a polyclonal T cell repertoire in the presence
of added TGF- and ATRA
To induce iT reg cells from the polyclonal repertoire, we
tested splenic BALB/c DCs as stimulators of C57BL/6 T cells
in a mixed leukocyte reaction (MLR) together with TGF-,
a known co-factor for iT reg cell development, according to
Chen et al. (2003). To deplete the starting B6 CD4+ responding T cells of preexisting T reg cells, we always used B6.FIR
mice in which the Foxp3 promoter drives RFP expression
(Wan and Flavell, 2005). CD4+CD25Foxp3 (RFP) cells
were isolated by FACS sorting and stimulated with DCs plus
2490

20 ng/ml TGF- alone or with ATRA, a recently described
co-factor for T reg cell development in the periphery
(see Introduction). Without TGF-, DCs induced a vigorous
MLR, but only 1% of proliferating CFSE-low cells was
Foxp3+. Addition of TGF- or TGF- plus ATRA greatly
increased the induction of CD4+CD25+Foxp3+ (RFP+) cells
to 20 and 70%, respectively, of the viable cells (Fig. 1 A,
left FACS). At an optimal dose of 20 ng/ml TGF-, increasing doses of ATRA up to 10 nM increased the frequency
and absolute number of induced CD4+CD25+Foxp3+ cells
(Fig. 1 A, right), with no induction by ATRA alone (not
depicted). Only the CD11c+ spleen cells induced T reg cells
(Fig. 1 B). Splenocytes selected by anti-CD11c beads are
not pure DCs, so we further separated them into CD11c
high, intermediate, and low fractions. The CD11c-high DCs,
which are also MHC II high, were the main active cells,
whereas CD11c-intermediate cells that include macrophages
and plasmacytoid DCs had much lower activity, and CD11clow lymphocytes were almost inactive (Fig. S1 A).
To test if the Foxp3+ iT reg cells exhibited suppressive
activity, 5-d MLR cultures were sorted into dominant RFP+
and minor CD4+CD25Foxp3 fractions that were then
added in graded doses to a fresh MLR between BALB/c DCs
and CD45.1+ CFSE-labeled CD4+ naive B6 T cells. At ratios
of 1:3 to 1:27 iT reg cells/fresh T cells, iT reg cells (Fig. 1 C,
blue triangles; and Fig. S1 B), but not Foxp3 cells (pink
squares), significantly suppressed the MLR. The suppression
by iT reg cells was equivalent to nT reg cells generated in the
presence of IL-2 as described previously (Yamazaki et al., 2006;
DCs induce stable antigen-specific T reg cells for adoptive transfer | Sela et al.

Downloaded from http://rupress.org/jem/article-pdf/208/12/2489/827490/jem_20110466.pdf by Rockefeller University user on 19 August 2020

Figure 1. DCs induce suppressive
CD4+CD25+Foxp3+ (RFP+) cells from a polyclonal
T cell repertoire. (A) Sorted C57BL/6
CD4+CD25Foxp3 (RFP) cells were cultured 5 d
with BALB/c splenic CD11c+ DCs alone (MLR), or with
20 ng/ml TGF- with or without graded doses of
ATRA. Typical FACS plots (top) and data on the frequency (bottom, blue) and absolute number (bottom,
red) of CD4+CD25+Foxp3+ (RFP+) iT reg cells at day 5
(mean ± SD). (B) As in A, but T reg cell induction
(dashed and solid lines indicate frequency and absolute number, respectively) in an MLR with CD11c+
DC-enriched (CD11c Pos) and CD11c DC-depleted
(CD11c Neg) BALB/c spleen cells with 20 ng/ml
TGF- and 10 nM ATRA. (C) iT reg cells, as well as
CD25Foxp3 (RFP; non T reg) cells, were isolated
from a day-5 MLR as in A. Cells were then added to a
fresh 5-d MLR between CFSE-labeled C57BL/6 CD45.1
CD4+ T cells and BALB/c DCs to detect suppressive
capacity (reduced CFSE dilution). We also tested
C57BL/6 Foxp3+ nT reg cells expanded in MLR with
IL-2. (D) As in C, but the suppressive activity of sorted
iT reg cells induced with 20 ng/ml TGF- alone or
together with ATRA were compared. (E) iT reg cells
generated as in A were added to cultures comprised
of BALB/c DCs and either CFSE-labeled naive C57BL/6 CD45.1+ CD4+ T cells (1° MLR) or sorted activated allospecific CD4+CD25+ cells generated from
CD4+CD25 cells in a 1° MLR (2° MLR). 5 d after addition of sorted iT reg cells, suppression of either 1 or 2° MLR was compared by calculating the percentage (% of MLR) of CFSE-diluted cells out of total proliferating cells in MLR (see Fig. S1 C) or percentage of CFSE-diluted cells. One representative experiment of three is shown. Error bars denote mean ± SD. *, P < 0.05.
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Fig. 1 C, green circles). iT reg cells generated with ATRA
were two- to threefold more effective on a cell-dose basis, indicating that ATRA improved iT reg cell induction both in
quantitative (Fig. 1 A) and qualitative (Fig. 1 D) terms. Given
these findings, we used T reg cells that were induced with
both ATRA and TGF- in all of the subsequent experiments.
To find out if iT reg cells could suppress an MLR when
the responding T cells had been preactivated, we isolated
activated CD4+CD25+Foxp3 cells at day 3–4 of an MLR
culture. When CFSE-labeled activated and naive C57BL/6
T cells were each challenged with allogeneic BALB/c DCs,
the proliferation of activated T cells in a 2° MLR was four
to five times stronger than the 1° MLR (Fig. S1 D, left data
points), as expected. Nevertheless, iT reg cells suppressed both

1° and 2° MLR whether we enumerated the Foxp3 response as frequency (Fig. 1 E) or total numbers (Fig. S1 D).
Therefore, DC-induced iT reg cells suppress secondary or
activated T cells at least as well as a primary response.
Polyclonal CD4+CD25+Foxp3+ iT reg cells are specific
for antigens on the inducing DC
To evaluate the antigenic specificity of suppression, we first induced C57BL/6 CD45.2+CD4+CD25Foxp3 (RFP) cells
to become iT reg cells with either BALB/c or SJL DCs. Then
we purified the RFP+ iT reg cells (suppressors) to test suppression of fresh C57BL/6 CD45.1+CD4+ cells in a primary
MLR stimulated with either BALB/c or SJL DCs (stimulators; Fig. S2). When iT reg cells had been induced by BALB/c
DCs, they more efficiently suppressed an
MLR stimulated by Balb DCs than iT reg
cells induced by SJL DCs (Fig. 2 A and
Fig. S2), whereas the reverse was observed
with an MLR stimulated with SJL DCs
(Fig. 2 B and Fig. S2). These “criss-cross”
experiments showed that DC-induced poly
clonal CD4+CD25+Foxp3+ iT reg cells specifically suppress MLR alloreactivity.
Figure 3. Splenic DCs specifically restimulate
allo-iT reg cells expansion. (A) Sorted iT reg cells
induced with either BALB/c or SJL CD11c+ DCs were
CFSE labeled and stimulated in various ratios with
either BALB/c (left) or SJL (right) CD11c+ DCs. (B) As
in A, but the restimulation cultures contained either
control or anti–TGF- mAb (left) or anti–IL-2 mAb
(right). 3 d later, live proliferating (CFSE diluted)
CD3+CD4+Foxp3+ (RFP+) cells were analyzed by FACS.
(C) Proliferating iT reg cells numbers with or without
restimulation with BALB/c DCs over 3 d. (D) As in C,
but after 3 d of DC restimulation, the CFSE-diluted
CD3+CD4+Foxp3+ (RFP+) iT reg cells and CD3+CD4+
Foxp3 (RFP) ex-Foxp3 cells were sorted and
incubated for 2 d, and IL-2 in the medium was
measured by ELISA. One representative experiment
of three is shown. Error bars denote mean ± SD.
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Figure 2. Polyclonal CD4+CD25+Foxp3+ iT reg cells are specific for antigens on the inducing DC. Sorted C57BL/6 CD4+CD25Foxp3 (RFP) cells were
incubated with either BALB/c (green) or SJL (gray) splenic CD11c+ DCs with TGF- and ATRA. After 5 d, the iT reg cells (CD4+CD25+Foxp3+RFP+) were sorted and
compared for suppression (as in Fig. 1 C) of an MLR (blue) stimulated with either BALB/c (A) or SJL (B) CD11c+ DCs. One representative experiment of four is
shown. Error bars denote mean ± SD. *, P < 0.05 comparing suppression between the two iT reg cells sources; **, P < 0.05 comparing suppression to MLR.

Splenic DCs specifically restimulate allo-iT reg cells
but independently of TGF-
To determine if iT reg cells could undergo restimulation, and
to further assess their specificity, we set up secondary DC restimulation cultures. Successful restimulation would also indicate that iT reg cells had a measure of stability, which to
our knowledge has not been established for antigen-specific
iT reg cells from the polyclonal repertoire. When B6 iT reg
cells were induced by BALB/c DCs, they were restimulated
more vigorously by BALB/c than SJL DCs (Fig. 3 A, left,
blue vs. pink), whereas iT reg cells induced by SJL DCs responded better to SJL versus BALB/c (Fig. 3 A, right, pink
vs. blue). In the suppression cultures, simultaneously with
suppression of T cell proliferation, the iT reg cells proliferated achieving a high ratio of CFSE-diluted iT reg cells to
suppressed CFSE-diluted T cells (Fig. S3 A).
To begin to understand mechanisms for restimulation by
DCs, we used blocking mAbs. Surprisingly restimulation of
iT reg cells no longer required TGF- (Fig. 3 B, left) but was

Table I.

Clinical manifestations

Induction + Prevention Alopecia
2 mo
PBS + PBS
CD4 + CD45RBhigh
+ PBS
CD4 + CD45RBhigh
+ iT reg cells

Alopecia
6 mo

Diarrhea
2 mo

Diarrhea
6 mo

A
C

A
—

No
Yes

No
—

A

B–C

No

No

C.B-17 scid (BALB/c) mice were transferred with allogeneic C57BL/6
CD4+CD45RBhiCD25CD45.1+ cells (induction) along with PBS or anti-Balb iT reg cells
(prevention). Control mice were injected twice with PBS (PBS + PBS). Skin manifestations
and diarrhea were evaluated 2 and 6 mo later. Grading of skin involvement: A, no
involvement; B, involvement of mouth or nose; C, involvement of back. Diarrhea was
graded as yes or no. — denotes that this mouse group did not survive.
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totally dependent on IL-2 (Fig. 3 B, right).
Kinetic studies showed that restimulated
iT reg cells were already expanding at
day 2 of the secondary cultures (Fig. 3 C,
left). Approximately 25–35% of the restim
ulated iT reg cells lost Foxp3 on day 2–3
(Fig. 3 C bottom right; and Fig. S3 B),
whereas in the absence of DCs, iT reg
cells did not proliferate (Fig. 3 C top
right) and only 5% lost Foxp3 (Fig. S3 B). When we sorted
Foxp3+ and Foxp3 cells from the restimulation cultures, only
Foxp3 or “ex- Foxp3” were producing IL-2 (Fig. 3 D). Also,
the sorted restimulated IL-2–dependent daughter Foxp3+ cells
were functional and able to suppress fresh T cell proliferation
(Fig. S3 C). These data indicate that polyclonal iT reg cells induced by DCs are able to be restimulated upon contact with
specific antigen and IL-2, and that most continue to express
Foxp3. Given these properties, we decided to proceed with
in vivo experiments to determine if iT reg cells could persist
under inflammatory conditions.
iT reg cells induced by DCs suppress GVHD.
To study the persistence and function of allospecific iT reg
cells in vivo, we created a GVHD model based on prior
work (Taylor et al., 2002). We transferred 106 C57BL/6
CD4+CD45RBhiCD25CD45.1+ cells into 4–5-wk non
irradiated BALB/c scid (C.B-17) mice lacking lymphocytes.
GVHD gradually developed over 1.5–2 mo with weight loss,
diarrhea, and skin lesions, including alopecia and eruptions,
starting around the eyes and nose and extending to the back
(Fig. S4 and Table I). Splenomegaly and lymphadenopathy
developed (Fig. S4), as well as systemic multiorgan inflammation mainly in the bowel, liver, skin, and lung, whereas the
disease-inducing C57BL/6 CD4+CD45RBhi cells infiltrated
these sites (not depicted). The mice lost weight progressively
and survived 2 mo on average (Fig. 4 A, right). Life spans
were shorter if more CD4+CD45RBhi cells were injected
(not depicted). When we simultaneously transferred C57BL/6
anti-BALB/c CD45.2+ iT reg cells, GVHD was markedly
attenuated, and the recipients of iT reg cells were almost free
of disease manifestations (Fig. 4 A, right; and Table I), for example, weight loss, skin involvement, and diarrhea, at a time
when most PBS-treated mice had died. To evaluate the
DCs induce stable antigen-specific T reg cells for adoptive transfer | Sela et al.
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Figure 4. iT reg cells induced by DCs suppress GVHD. (A) C.B-17 scid (BALB/c) mice
were transferred with allogeneic C57BL/6
CD4+CD45RBhiCD25 CD45.1 (disease inducing)
cells along with PBS or anti-Balb iT reg cells. In
parallel, control mice were injected twice with
PBS (PBS+PBS). Animal survival (left) and weight
(right) were followed. (B) H&E inflammation
score of tissues 2–2.5 mo after disease induction
with CD4+ CD45.1 T cells, with or without prevention with CD4+ CD45.2 Foxp3+(RFP+) cells.
One representative experiment of three is
shown. Error bars denote mean ± SD.

Ar ticle

length of the remission brought about with iT reg cells, we
followed the mice for 6 mo. In three experiments, mice
treated with iT reg cells survived for 6 mo after disease induction (Fig. 4 A), whereas none of the mice induced with
CD4+CD45RBhi cells and treated with PBS survived 2.5 mo.
This was associated with a significantly better H&E inflammation score of several organs (Fig. 4 B). Thus, DC-induced
antigen-specific iT reg cells can prevent GVHD, extending
prior evidence that adoptively transferred nT reg cells also
can prevent GVHD (Joffre et al., 2008).
Alloreactive DC-induced T reg cells remain stable
for months in vivo and acquire highly demethylated
foxp3 CNS2 gene sequences
To determine if the transferred iT reg cells persisted in these
recipients, we looked for CD45.2+ cells 2.5 mo after adoptive
transfer. Many CD45.2+CD4+Foxp3+ cells were observed in
all organs tested, including lymphoid tissues (Fig. S5 A), liver,
and lung (not depicted). Although these mice were clinically
healthy, we could find disease-inducing CD45.1+ cells in
all these sites (Fig. S5), suggesting that iT reg cells did not
JEM Vol. 208, No. 12

eliminate disease-inducing cells but rather
suppressed them. When we followed the
mice for longer periods, iT reg cells were
found in lymphoid and other organs 6 mo
after adoptive transfer (Fig. 5 A), although
the mice were starting to have signs of
GVHD (Table I and Fig. S4 D).
Because previous studies attributed therapeutic failures with iT reg cells to Foxp3
gene instability (Edinger, 2009), we studied
CpG methylation status in CNS2 (Fig. 5 B),
a region of the Foxp3 gene linked to maintenance and stability of this transcription
factor (Zheng et al., 2010). Immediately after induction, iT reg
cells had almost fully methylated CpG in CNS2 (Fig. 5 B)
compared with demethylation in nT reg cells. However,
CNS2 demethylation in iT reg cells increased significantly 3 d
after restimulation in vitro but, more strikingly, 1.5 mo after
transfer of the iT reg cells in vivo, when demethylation
matched nT reg cells (Fig. 5 B). Thus iT reg cells stability and
Foxp3 CNS2 demethylation are both associated with prolonged iT reg cells survival and GVHD remission in vivo.
iT reg cells induced by DCs can treat active GVHD
To verify that iT reg cells can persist and function when
adoptively transferred under ongoing conditions of inflammation and active GVHD, we conducted a treatment experiment. The mice were treated with iT reg cells at 2 wk, after
the onset of weight loss (Fig. 5 C) and up-regulation in IFN-
(not depicted), and compared with control and prevention
groups (iT reg cell treatment at time 0). After treatment with
iT reg cells, the mice were monitored for an additional 7 wk.
The iT reg cell–treated sick mice regained weight to an almost equivalent level to that of healthy control mice and
2493
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Figure 5. iT reg cells induced by DCs persist
in vivo and remain stable. (A) C.B-17 scid (BALB/c)
mice were transferred with allogeneic (C57BL/6)
CD4+CD45RBhiCD25 CD45.1 disease-inducing cells
along with either PBS or with anti-Balb iT reg cells.
Infiltration of secondary lymphoid organs and tissues with CD4+ CD45.1 disease-inducing cells and
CD4+CD45.2 Foxp3+ (RFP+) disease protective cells
was analyzed by FACS 6 mo after GVHD induction.
(B) iT reg cells from a primary MLR (iT reg cells) or
restimulated (3 d) with allo DC (restimulated iT reg
cells), or iT reg cells 1.5 mo after adoptive transfer
(in vivo iT reg cells), were compared with naive CD4+
cells or nT reg cells for CpG dinucleotide methylation
at CNS2 of the Foxp3 gene by Bisulfite pyrosequencing. (C) As in Fig. 4 A, but with an additional group of
mice that were injected with iT reg cells as treatment
only after the appearance of weight loss at 2 wk.
(D) Infiltration of secondary lymphoid organs and
tissues with CD4+ CD45.1 and CD4+ CD45.2 Foxp3+
(RFP+) of sick mice that were treated with iT reg cells.
One representative experiment of three is shown.
Error bars denote mean ± SD. *, P < 0.05.

equivalent to mice that were given iT reg cells as prevention.
This is in contrast to untreated mice that continued to lose
weight (Fig. 5 C), developed skin manifestation and diarrhea,
and died early (not depicted). This significant improvement
with treatment was accompanied by the persistence of iT reg
cells in secondary lymphoid tissues and organs 7 wk after
iT reg cell adoptive transfer to sick mice (Fig. 5 D).

2494

MATERIALS AND METHODS
Mice. We purchased 6–8-wk-old female BALB/c H-2d, C57BL/6 CD45.1
H-2b, and SJL H-2s mice from Taconic and 3–4-wk-old C.B-17 scid (BALB/
c background) mice from The Jackson Laboratory. Foxp3-IRES-RFP (FIR)
knock-in mice were a gift from R. Flavell (Yale University, New Haven,
CT; Wan and Flavell, 2005). We followed guidelines of the institutional animal care and use committee of the Rockefeller University.
Antibodies and reagents. We purchased from BD APC conjugated anti–
mouse CD25, -CD4, -CD45.1, and -CD11c; Alexa Fluor 700–conjugated
anti-CD3, -CD4, and -CD11c; PE-conjugated anti-CD3, -CD19, and
-CD49b; FITC-conjugated anti-CD3, -CD19, -CD49b, and isotype control; biotin anti-CD4, -CD8, -DX5, -B220, -CD3, -CD11b, -Ly-6G, and
-Ter119; and purified anti-CD16/CD32 (2.4G2). We purchased CD11c
and streptavidin beads (SA) from Miltenyi Biotec; CFSE and live dead fixable aqua from Invitrogen; ATRA from Sigma-Aldrich; human TGF-1,
anti–mouse TGF- (1D11), anti–IL-2, and Ig isotype control from R&D
Systems; and IL-2 from Novartis or PeproTech.
T cells and DCs. Non-CD4+ lymph node and spleen T cells were removed by MACS beads (Miltenyi Biotec) after coating with biotin antiCD8, DX5, B220, CD3, CD11b, Ly-6G, and Ter119 and were further
purified with a FACSAria 2 sorter (BD) to >97%. Spleen CD11c+ DCs were
partially enriched with anti-CD11c beads (Miltenyi Biotec) and, where indicated, purified with a FACSAria 2 or FACSVantage (BD) cell sorter as
CD11chighCD19CD3DX5 DCs (>95%).
De novo in vitro induction of T reg cells in the allo-MLR. CD4+
T cells from C57BL/6 Foxp3 RFP mice were sorted as CD4+CD25RFP
cells. These T cells were then co-cultured for 5 d with fresh splenic BALB/c
DCs. Induction of CD4+CD25+RFP+ cells was analyzed by FACS (LSR-II;
BD) and FlowJo software (Tree Star) and sorted (FACSAria 2) as needed for
functional assays.
In vitro suppression assay. iT reg cells or activated nT reg cells
(CD4+CD25+RFP+ from naive mice activated for 5 d with allo-DCs)
were co-cultured in round-bottom 96-well plates with CFSE-labeled fresh
DCs induce stable antigen-specific T reg cells for adoptive transfer | Sela et al.
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DISCUSSION
We have chosen the MLR to generate antigen-specific iT reg
cells from a polyclonal repertoire because many T cells are
allospecific (Steinman and Witmer, 1978), and there are excellent models of GVHD to study the in vivo function of the
iT reg cells. It is known that DCs induce Foxp3+ T reg cells
through endogenous (Coombes et al., 2007; Sun et al., 2007;
Yamazaki et al., 2007) or exogenous (Luo et al., 2007) TGF-,
using stimulation of bulk populations with anti-CD3 or TCR
transgenic T cells with antigen. In this study, we used BALB/c
DCs to present antigens to polyclonal allogeneic C57BL/6
Foxp3CD4+ T cells in the presence of TGF- and ATRA
(although the iT reg cells were also induced when the MLR
was run in the reverse direction; unpublished data). We found
that the DCs induced iT reg cells efficiently because most of
the MLR proliferating cells became Foxp3+ at a DC/T cell
ratio of 1:10.These iT reg cells specifically suppressed alloimmunity in vitro, both by naive and previously activated T cells
(primary and secondary MLR). Importantly, the iT reg cells
also suppressed active GVHD and persisted in vivo under conditions of inflammation, although in vivo conversion to exFoxp3 cells was observed (25–30%; Fig. S5 B).
The development of clinical manifestations of GVHD
after 6 mo suggests that treatment with iT reg cells in our experiments does not bring to cure, as although they persisted,
the iT reg cells did not eliminate the disease-inducing cells
(2.5 and 6 mo after adoptive transfer) but rather induced prolonged remission. If treatment with iT reg cells will come to
patients in the future, this may suggest that at this point when
there is relapse in clinical manifestations, a boost with iT reg
cells might be given to renew the remission. In addition, regarding the possibility that iT reg cells converted to ex-Foxp3
will mediate development of GVHD, we injected iT reg cells
alone and monitored the mice for 2 mo. During this time, we
did not observe any clinical change comparing to healthy
mice (unpublished data).
The latter findings were surprising because prior publications questioned the stability of Foxp3+ expression by in vitro
generated iT reg cells (Floess et al., 2007). Because of this instability, the therapeutic use of iT reg cells was questioned
(Sakaguchi et al., 2008; Edinger, 2009). However, iT reg
cells were not previously shown to undergo restimulation
in vitro with DCs from lymphoid tissues, which are known to
induce T reg cells from antigen-specific TCR transgenic
T cells (Kretschmer et al., 2005; Luo et al., 2007; Yamazaki
et al., 2007).
We found, in contrast to previous publication (Floess et al.,
2007; Polansky et al., 2008; Koenecke et al., 2009), that fresh

DCs alone can restimulate iT reg cells that maintain a high
rate of Foxp3 expression without the need for exogenous
cytokine supplementation. Perhaps our results reflect the
very high frequency of iT reg cells in our primary MLR cultures. Nevertheless, not all Foxp3+ iT reg cells induced in a
primary MLR were stable. A minority lost Foxp3 expression
when rechallenged with DCs, and began to make IL-2 (most
of the ex-Foxp3 cells were described to be methylated; Zhou
et al., 2009). The population of iT reg cells that maintained
Foxp3 exhibited higher levels of CNS2 demethylation in
the Foxp3 gene, a marker for stability. IL-2 is known to
maintain Foxp3+ nT reg cells in vivo (Oldenhove et al., 2009;
Grinberg-Bleyer et al., 2010), and we found that IL-2 generated by ex-Foxp3 cells, but not TGF-, was required for
DCs to restimulate iT reg cells. Several recent publications
(Wan and Flavell, 2005, 2007; Tang et al., 2008; Yang et al.,
2008; Murai et al., 2009; Zhou et al., 2009) have reported
that T reg cells in the context of inflammation lower Foxp3
expression. In contrast, the DC-induced iT reg cells we studied were specifically suppressive and a significant fraction was
able to persist and function in vivo and under inflammatory
conditions. This encourages the use of DCs to generate antigenspecific iT reg cells for therapeutic use.

Ar ticle

CD45.1+CD4+ T cells at the indicated ratios plus allo-DCs (ratio of 1 DC to 3
CD45.1+ CD4+ T cells). After 5 d, proliferation was assessed by FACS
(LSR-II; BD) to determine CFSE diluted, live CD45.1+ T cells. Statistical
data (Student’s t test) were analyzed using Excel (Microsoft).
Restimulation of iT reg cells. Sorted DC-induced T reg cells were labeled with CFSE and recultured with fresh allo-DCs for several days as indicated, after which CFSE dilution as a marker for iT reg cells proliferation
was analyzed by FACS (LSR-II).

Methylation analysis. CpG dinucleotide methylation analysis of the Foxp3
CNS2 (Zheng et al., 2010) sequence was determined by bisulfite treatment
of RNase-treated genomic DNA, followed by PCR amplification and pyrosequencing. Pyro Q–CpG was performed by EpigenDX.
Online supplemental material. Fig. S1 shows that DCs generate
de novo suppressive CD4+CD25+Foxp3+ (RFP+) from a polyclonal T cell
repertoire in the MLR. Fig. S2 shows that polyclonal CD4+CD25+Foxp3+
iT reg cells are specific for antigens on the inducing DC. Fig. S3 shows
that splenic DCs efficiently restimulate allo–iT reg cells that maintain their
suppressive activity. Fig. S4 shows that iT reg cells induced by DCs suppress GVHD in vivo. Fig. S5 shows that iT reg cells induced by DCs persist in vivo. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20110466/DC1.
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